0LB

(1R,2R)-N-(1-cyanocyclopropyl)-2-{[4-(4-fluorophenyl)piperazin-1-yl]carbonyl}cyclohexanecarboxamide

Created:	2012-07-01
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where 0LB is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	56
Chiral Atom Count	2
Bond Count	59
Aromatic Bond Count	6

2D diagram of 0LB

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(1R,2R)-N-(1-cyanocyclopropyl)-2-{[4-(4-fluorophenyl)piperazin-1-yl]carbonyl}cyclohexanecarboxamide
Systematic Name (OpenEye OEToolkits)	(1R,2R)-N-(1-cyanocyclopropyl)-2-[4-(4-fluorophenyl)piperazin-1-yl]carbonyl-cyclohexane-1-carboxamide
Formula	C₂₂ H₂₇ F N₄ O₂
Molecular Weight	398.474
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(N2CCN(c1ccc(F)cc1)CC2)C4CCCCC4C(=O)NC3(C#N)CC3
SMILES	CACTVS	3.370	Fc1ccc(cc1)N2CCN(CC2)C(=O)[CH]3CCCC[CH]3C(=O)NC4(CC4)C#N
SMILES	OpenEye OEToolkits	1.7.6	c1cc(ccc1N2CCN(CC2)C(=O)C3CCCCC3C(=O)NC4(CC4)C#N)F
Canonical SMILES	CACTVS	3.370	Fc1ccc(cc1)N2CCN(CC2)C(=O)[C@@H]3CCCC[C@H]3C(=O)NC4(CC4)C#N
Canonical SMILES	OpenEye OEToolkits	1.7.6	c1cc(ccc1N2CCN(CC2)C(=O)[C@@H]3CCCC[C@H]3C(=O)NC4(CC4)C#N)F
InChI	InChI	1.03	InChI=1S/C22H27FN4O2/c23-16-5-7-17(8-6-16)26-11-13-27(14-12-26)21(29)19-4-2-1-3-18(19)20(28)25-22(15-24)9-10-22/h5-8,18-19H,1-4,9-14H2,(H,25,28)/t18-,19-/m1/s1
InChIKey	InChI	1.03	GHDIYQHGVKVLJX-RTBURBONSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL2070936
PubChem	70278898
ChEMBL	CHEMBL2070936

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.